Red Blood Cell (RBC) membrane proteomics - Part II: Comparative proteomics and RBC patho-physiology

Journal of Proteomics

Volumn 73, Issue 3, 2010, Pages 421-435

  Pasini, Erica M ^a   Lutz, Hans U ^b   Mann, Matthias ^c   Thomas, Alan W ^a  

^a BIOMEDICAL PRIMATE RESEARCH CENTRE   (Netherlands)

^b ETH ZURICH   (Switzerland)

^c MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

Author keywords

Comparative proteomics; Membrane; Patho physiology; Red blood cell

Indexed keywords

CIRCUMSPOROZOITE PROTEIN; CYTOSKELETON PROTEIN; LIVER STAGE ANTIGEN; MALARIA VACCINE; MEMBRANE PROTEIN; MEROZOITE SURFACE PROTEIN 1; MEROZOITE SURFACE PROTEIN 2; MEROZOITE SURFACE PROTEIN 3; MEROZOITE SURFACE PROTEIN 5; PARASITE ANTIGEN; SPOROZOITE LIVER STAGE ANTIGEN; SPOROZOITE SURFACE PROTEIN; SPOROZOITE THREONINE ASPARAGINE RICH PROTEIN; UNCLASSIFIED DRUG;

ANEMIA; BLOOD GROUP; BLOOD TRANSFUSION; ERYTHROCYTE DEFORMABILITY; ERYTHROCYTE FUNCTION AND CHARACTERISTICS; ERYTHROCYTE MEMBRANE; GENE LOCUS; HOMEOSTASIS; HUMAN; LIPID RAFT; NEOPLASM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEOMICS; REVIEW; SICKLE CELL ANEMIA; SPECIES DIFFERENCE; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

ANEMIA; ANIMALS; BLOOD TRANSFUSION; DISEASE; ERYTHROCYTE MEMBRANE; ERYTHROCYTES; HOMEOSTASIS; HUMANS; MODELS, BIOLOGICAL; PROTEOMICS; TRANSPLANTATION, HETEROLOGOUS;

EID: 72149087442     PISSN: 18743919     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jprot.2009.07.004     Document Type: Review

References (89)

1. Ruud J.T. Vertebrates without erythrocytes and blood pigment. Nature 1 (1954) 7848-7850
2. Kim H.R., Shin M.G., Kim M.J., Kim H.J., Shin J.H., Suh S.P., et al. Mitochondrial DNA aberrations of bone marrow cells from patients with aplastic anemia. J Korean Med Sci 23 6 (2008) 1062-1067
3. Sawada K., Fujishima N., and Hirokawa M. Acquired pure red cell aplasia: updated review of treatment. Br J Haematol 142 4 (2008) 505-514
4. Okan V., Cigiloglu A., Cifci S., Yilmaz M., and Pehlivan M. Red cell indices and functions differentiating patients with the beta-thalassaemia trait from those with iron deficiency anaemia. J Int Med Res 37 1 (2009) 25-30
5. Steinberg M.H. Sickle cell anemia, the first molecular disease: overview of molecular etiology, pathophysiology, and therapeutic approaches. Sci World J 8 (2008) 1295-1324
6. Yawata Y. Cell Membrane: The Red Blooc Cell as a Model (2003), Wiley-VCH, Weinheim
7. An X., and Mohandas N. Disorders of red cell membrane. Br J Haematol 141 3 (2008) 367-375
8. McMullin M.F. The classification and diagnosis of erythrocytosis. Int J Lab Hematol 30 6 (2008) 447-455
9. Guéant J.L., Safi A., Aimone-Gastin I., Rabesona H., Bronowicki J.P., Plénat F., et al. Autoantibodies in pernicious anemia type I patients recognize sequence 251-256 in human intrinsic factor. Proc Assoc Am Physicians 109 5 (1997) 462-469
10. Stijlemans B., Vankrunkelsven A., Brys L., Magez S., and De Baetselier P. Role of iron homeostasis in trypanosomiasis-associated anemia. Immunobiology 213 9-10 (2008) 823-835
11. Cowman A.F., and Crabb B.S. Invasion of red blood cells by malaria parasites. Cell 124 4 (2006) 755-766
12. Yokoyama N., Okamura M., and Igarashi I. Erythrocyte invasion by Babesia parasites: current advances in the elucidation of the molecular interactions between the protozoan ligands and host receptors in the invasion stage. Vet Parasitol 138 1-2 (2006) 22-32
13. Hagiwara K., Ichikawa T., and Takahashi K. Studies on an experimental system for the invasion of Theileria sergenti merozoite into erythrocytes. Vet Parasitol 63 3-4 (1996) 187-193
14. Paterson W.B., Desser S.S., and Barta J.R. Ultrastructural features of the apical complex, pellicle, and membranes investing the gamonts of Haemogregarina magna (Apicomplexa: Adeleina). J Protozool 35 1 (1988) 73-80
15. Zolla L. Proteomics and transfusion medicine. Blood Transfus 6 2 (2008) 67-69
16. D'Amici G.M., Rinalducci S., and Zolla L. Proteomic analysis of RBC membrane protein degradation during blood storage. J Proteome Res 6 (2007) 3242-3255
17. Anniss A.M., Glenister K.M., Killian J.J., and Sparrow R.L. Proteomic analysis of supernatants of stored red blood cell products. Transfusion 45 (2005) 1426-1433
18. Queloz P.A., Thadikkaran L., Crettaz D., Rossier J.S., Barelli S., and Tissot J.D. Proteomics and transfusion medicine: future perspectives. Proteomics 6 (2006) 5605-5614
19. Bosman G.J., Lasonder E., Luten M., Roerdinkholder-Stoelwinder B., Novotny V.M., Bos H., et al. The proteome of red cell membranes and vesicles during storage in blood bank conditions. Transfusion 48 (2008) 827-835
20. Sparrow R.L., Healey G., Patton K.A., and Veale M.F. Red blood cell age determines the impact of storage and leukocyte burden on cell adhesion molecules, glycophorin A and the release of annexin V. Transfus Apher Sci 34 (2006) 15-23
21. Liumbruno G., D'Amici G.M., Grazzini G., and Zolla L. Transfusion medicine in the era of proteomics. J Proteomics 71 1 (2008) 34-45
22. Koch C.G., Li L., Sessler D.I., Figueroa P., Hoeltge G.A., Mihaljevic T., et al. Duration of red-cell storage and complications after cardiac surgery. N Engl J Med 358 (2008) 1229-1239
23. Lutz H.U., Stammler P., Fasler S., Ingold M., and Fehr J. Density separation of human red blood cells on self forming Percoll gradients: correlation with cell age. Biochim Biophys Acta 1116 (1992) 1-10
24. Goardon N., Lambert J.A., Rodriguez P., Nissaire P., et al. ETO2 coordinates cellular proliferation and differentiation during erythropoiesis. Embo J 25 (2006) 357-366
25. Brand M., Ranish J.A., Kummer N.T., Hamilton J., et al. Dynamic changes in transcription factor complexes during erythroid differentiation revealed by quantitative proteomics. Nat Struct Mol Biol 11 (2004) 73-80
26. Unwin R.D., Smith D.L., Blinco D., Wilson C.L., et al. Quantitative proteomics reveals posttranslational control as a regulatory factor in primary hematopoietic stem cells. Blood 107 (2006) 4687-4694
27. Claverol S., Burlet-Schiltz O., Girbal-Neuhauser E., Gairin J.E., and Monsarrat B. Mapping and structural dissection of human 20 S proteasome using proteomic approaches. Mol Cell Proteomics 1 (2002) 567-578
28. Froment C., Uttenweiler-Joseph S., Bousquet-Dubouch M.P., Matondo M., et al. A quantitative proteomic approach using two-dimensional gel electrophoresis and isotope-coded affinity tag labeling for studying human 20S proteasome heterogeneity. Proteomics 5 (2005) 2351-2363
29. 2+)-induced vesiculation in stomatin-deficient overhydrated hereditary stomatocytosis. Biochim Biophys Acta 1778 (2008) 125-132
30. Denecke J., Kranz C., Nimtz M., Conradt H.S., et al. Characterization of the N-glycosylation phenotype of erythrocyte membrane proteins in congenital dyserythropoietic anemia type II (CDA II/HEMPAS). Glycoconj J (2007)
31. De Franceschi L., Biondani A., Carta F., Turrini F., Laudanna C., Deana R., et al. PTPepsilon has a critical role in signaling transduction pathways and phosphoprotein network topology in red cells. Proteomics 8 (2008) 4695-4708
32. Unwin R.D., Harnden P., Pappin D., Rahman D., et al. Serological and proteomic evaluation of antibody responses in the identification of tumor antigens in renal cell carcinoma. Proteomics 3 (2003) 45-55
33. Scanlan M.J., Gordan J.D., Williamson B., Stockert E., et al. Antigens recognized by autologous antibody in patients with renal-cell carcinoma. Int J Cancer 83 (1999) 456-464
34. Lutz H.U. Homeostatic roles of naturally occurring antibodies: an overview. J Autoimmun 29 (2007) 287-294
35. Avrameas S., Ternynck T., Tsonis I.A., and Lymberi P. Naturally occurring B-cell autoreactivity: a critical overview. J Autoimmun 29 (2007) 213-218
36. Girard M.P., Reed Z.H., Friede M., and Kieny M.P. A review of human vaccine research and development: malaria. Vaccine 25 (2007) 1567-1580
37. Lyon J.A., Thomas A.W., Hall T., and Chulay J.D. Specificities of antibodies that inhibit merozoite dispersal from malaria-infected erythrocytes. Mol Biochem Parasitol 36 (1989) 77-85
38. Florens L., Washburn M.P., Raine J.D., Anthony R.M., et al. A proteomic view of the Plasmodium falciparum life cycle. Nature 419 (2002) 520-526
39. Lasonder E., Ishihama Y., Andersen J.S., Vermunt A.M., et al. Analysis of the Plasmodium falciparum proteome by high-accuracy mass spectrometry. Nature 419 (2002) 537-542
40. Sims P.F., and Hyde J.E. Proteomics of the human malaria parasite Plasmodium falciparum. Expert Rev Proteomics 3 (2006) 87-95
41. Vincensini L., Richert S., Blisnick T., Van Dorsselaer A., et al. Proteomic analysis identifies novel proteins of the Maurer's clefts, a secretory compartment delivering Plasmodium falciparum proteins to the surface of its host cell. Mol Cell Proteomics 4 (2005) 582-593
42. Graves P.R., Kwiek J.J., Fadden P., Ray R., Hardeman K., Coley A.M., et al. Discovery of novel targets of quinoline drugs in the human purine binding proteome. Mol Pharmacol 62 (2002) 1364-1372
43. Jiang M., Jia L., Jiang W., Hu X., et al. Protein disregulation in red blood cell membranes of type 2 diabetic patients. Biochem Biophys Res Commun 309 (2003) 196-200
44. Bryant N.J., Govers R., and James D.E. Regulated transport of the glucose transporter GLUT4. Nat Rev Mol Cell Biol 3 (2002) 267-277
45. Pasini E.M., Kirkegaard M., Mortensen P., Lutz H.U., et al. In-depth analysis of the membrane and cytosolic proteome of red blood cells. Blood 108 (2006) 791-801
46. Jiang M., Ding Y., Su Y., Hu X., et al. Arginase-flotillin interaction brings arginase to red blood cell membrane. FEBS Lett 580 (2006) 6561-6564
47. Marinkovic D., Zhang X., Yalcin S., Luciano J.P., et al. Foxo3 is required for the regulation of oxidative stress in erythropoiesis. J Clin Invest 117 (2007) 2133-2144
48. Friedman J.S., Lopez M.F., Fleming M.D., Rivera A., et al. SOD2-deficiency anemia: protein oxidation and altered protein expression reveal targets of damage, stress response, and antioxidant responsiveness. Blood 104 (2004) 2565-2573
49. Lutz H.U. Innate immune and non-immune mediators of erythrocyte clearance. Cell Mol Biol (Noisy-le-grand) 50 (2004) 107-116
50. Gauthier D.J., Gibbs B.F., Rabah N., and Lazure C. Utilization of a new biotinylation reagent in the development of a nondiscriminatory investigative approach for the study of cell surface proteins. Proteomics 4 (2004) 3783-3790
51. Olsen J.V., Andersen J.R., Nielsen P.A., Nielsen M.L., et al. HysTag - a novel proteomic quantification tool applied to differential display analysis of membrane proteins from distinct areas of mouse brain. Mol Cell Proteomics 3 (2004) 82-92
52. Starita-Geribaldi M., Thebault P., Taffin de Givenchy E., Guittard F., and Geribaldi S. 2-DE using hemi-fluorinated surfactants. Electrophoresis 28 (2007) 2489-2497
53. Salzer U., and Prohaska R. Stomatin, flotillin-1, and flotillin-2 are major integral proteins of erythrocyte lipid rafts. Blood 97 (2001) 1141-1143
54. Miwa T., and Song W.C. Membrane complement regulatory proteins: insight from animal studies and relevance to human diseases. Int Immunopharmacol 1 (2001) 445-459
55. Murphy S.C., Samuel B.U., Harrison T., Speicher K.D., et al. Erythrocyte detergent-resistant membrane proteins: their characterization and selective uptake during malarial infection. Blood 103 (2004) 1920-1928
56. Murphy S.C., Fernandez-Pol S., Chung P.H., Prasanna Murthy S.N., et al. Cytoplasmic remodeling of erythrocyte raft lipids during infection by the human malaria parasite Plasmodium falciparum. Blood 110 (2007) 2132-2139
57. Thadikkaran L., Siegenthaler M.A., Crettaz D., Queloz P.A., et al. Recent advances in blood-related proteomics. Proteomics 5 (2005) 3019-3034
58. Kakhniashvili D.G., Griko N.B., Bulla Jr. L.A., and Goodman S.R. The proteomics of sickle cell disease: profiling of erythrocyte membrane proteins by 2D-DIGE and tandem mass spectrometry. Exp Biol Med (Maywood) 230 (2005) 787-792
59. Haynes Jr. J., Obiako B., King J.A., Hester R.B., and Ofori-Acquah S. Activated neutrophil-mediated sickle red blood cell adhesion to lung vascular endothelium: role of phosphatidylserine-exposed sickle red blood cells. Am J Physiol Heart Circ Physiol 291 (2006) H1679-1685
60. Haynes Jr. J., Obiako B., Hester R.B., Baliga B.S., and Stevens T. Hydroxyurea attenuates activated neutrophil-mediated sickle erythrocyte membrane phosphatidylserine exposure and adhesion to pulmonary vascular endothelium. Am J Physiol Heart Circ Physiol 294 (2008) H379-385
61. Ghatpande S.S., Choudhary P.K., Quinn C.T., and Goodman S.R. Pharmaco-proteomic study of hydroxyurea-induced modifications in the sickle red blood cell membrane proteome. Exp Biol Med (Maywood) 233 (2008) 1510-1517
62. Yipp B.G., Anand S., Schollaardt T., Patel K.D., et al. Synergism of multiple adhesion molecules in mediating cytoadherence of Plasmodium falciparum-infected erythrocytes to microvascular endothelial cells under flow. Blood 96 (2000) 2292-2298
63. Luginbuhl A., Nikolic M., Beck H.P., Wahlgren M., and Lutz H.U. Complement factor D, albumin, and immunoglobulin G anti-band 3 protein antibodies mimic serum in promoting rosetting of malaria-infected red blood cells. Infect Immun 75 (2007) 1771-1777
64. McCormick C.J., Craig A., Roberts D., Newbold C.I., and Berendt A.R. Intercellular adhesion molecule-1 and CD36 synergize to mediate adherence of Plasmodium falciparum-infected erythrocytes to cultured human microvascular endothelial cells. J Clin Invest 100 (1997) 2521-2529
65. Wu Y., and Craig A. Comparative proteomic analysis of metabolically labelled proteins from Plasmodium falciparum isolates with different adhesion properties. Malar J 5 (2006) 67
66. Tripathi A.K., Sullivan D.J., and Stins M.F. Plasmodium falciparum-infected erythrocytes increase intercellular adhesion molecule 1 expression on brain endothelium through NF-kappaB. Infect Immun 74 (2006) 3262-3270
67. Viebig N.K., Wulbrand U., Forster R., Andrews K.T., et al. Direct activation of human endothelial cells by Plasmodium falciparum-infected erythrocytes. Infect Immun 73 (2005) 3271-3277
68. Brown M.D., Wick T.M., and Eckman J.R. Activation of vascular endothelial cell adhesion molecule expression by sickle blood cells. Pediatr Pathol Mol Med 20 (2001) 47-72
69. Chakravorty S.J., Carret C., Nash G.B., and Ivens A.e.t.a.l. Altered phenotype and gene transcription in endothelial cells, induced by Plasmodium falciparum-infected red blood cells: pathogenic or protective?. Int J Parasitol 37 (2007) 975-987
70. Bertonati C., and Tramontano A. A model of the complex between the PfEMP1 malaria protein and the human ICAM-1 receptor. Proteins 69 (2007) 215-222
71. Durr E., Yu J., Krasinska K.M., Carver L.A., et al. Direct proteomic mapping of the lung microvascular endothelial cell surface in vivo and in cell culture. Nat Biotechnol 22 (2004) 985-992
72. Fried M., Hixson K.K., Anderson L., Ogata Y., et al. The distinct proteome of placental malaria parasites. Mol Biochem Parasitol 155 (2007) 57-65
73. Ward P.A. The dark side of C5a in sepsis. Nat Rev Immunol 4 (2004) 133-142
74. Fleming S.D., and Tsokos G.C. Complement, natural antibodies, autoantibodies and tissue injury. Autoimmun Rev 5 (2006) 89-92
75. Sasaki T., Takahashi T., Maeshima K., Shimizu H., et al. Heme arginate pretreatment attenuates pulmonary NF-kappaB and AP-1 activation induced by hemorrhagic shock via heme oxygenase-1 induction. Med Chem 2 (2006) 271-274
76. Kean L.S., Brown L.E., Nichols J.W., and Mohandas N.e.t.a.l. Comparison of mechanisms of anemia in mice with sickle cell disease and beta-thalassemia: peripheral destruction, ineffective erythropoiesis, and phospholipid scramblase-mediated phosphatidylserine exposure. Exp Hematol 30 (2002) 394-402
77. Siegel B.V., Weaver W.J., and Koler R.D. Mouse erythroleukemia of viral etiology. Nature 201 (1964) 1042-1043
78. Lorant T., Wilton J., Olausson M., Tufveson G., and Johnsson C. Oral administration of xenogeneic erythrocytes induces production of antibodies that are capable of inducing hyperacute rejection of concordant vascularized xenografts. Transplantation 77 (2004) 1100-1103
79. Yang B., and Verkman A.S. Analysis of double knockout mice lacking aquaporin-1 and urea transporter UT-B. Evidence for UT-B-facilitated water transport in erythrocytes. J Biol Chem 277 (2002) 36782-36786
80. Pasini, E.M., Kirkegaard, M., Salerno, D., Mortensen, P. et al., Deep-coverage mouse red blood cell proteome: a first comparison with the human red blood cell, submitted to Molecular and Cellular Proteomics 2007.
81. Resmi H., Akhunlar H., Temiz Artmann A., and Guner G. In vitro effects of high glucose concentrations on membrane protein oxidation, G-actin and deformability of human erythrocytes. Cell Biochem Funct 23 3 (2005) 163-168
82. Muro A.F., Marro M.L., Gajovic S., Porro F., Luzzatto L., and Baralle F.E. Mild spherocytic hereditary elliptocytosis and altered levels of alpha- and gamma-adducins in beta-adducin-deficient mice. Blood 95 12 (2000) 3978-3985
83. Babcock G.G., and Fowler V.M. Isoform-specific interaction of tropomodulin with skeletal muscle and erythrocyte tropomyosins. J Biol Chem 269 44 (1994) 27510-27518
84. Campanella M.E., Chu H., and Low P.S. Assembly and regulation of a glycolytic enzyme complex on the human erythrocyte membrane. . Proc Natl Acad Sci U S A 102 (2005) 2402-2407
85. Schrier S.L., Ben-Bassat I., Junga I., Seeger M., and Grumet F.C. Characterization of erythrocyte membrane-associated enzymes (glyceraldehyde-3-phosphate dehydrogenase and phosphoglyceric kinase. J Lab Clin Med 85 5 (1975) 797-810
86. Prenni J.E., Avery A.C., and Olver C.S. Proteomics: a review and an example using the reticulocyte membrane proteome. Vet Clin Pathol 36 (2007) 13-24
87. Fischer T.M. Cross bonding and stiffening of the red cell membrane. Biochim Biophys Acta 985 (1989) 218-228
88. Prabakaran S., Wengenroth M., Lockstone H.E., Lilley K., et al. 2-D DIGE analysis of liver and red blood cells provides further evidence for oxidative stress in schizophrenia. J Proteome Res 6 (2007) 141-149
89. Yoo K.Y., Shin H.R., Chang S.H., Choi B.Y., et al. Genomic epidemiology cohorts in Korea: present and the future. Asian Pac J Cancer Prev 6 (2005) 238-243